Corvus Capital

Along with its own capital, Corvus has the backing of a number of international funding partners. Our considered approach over the last decade has created over $5BN of value for investors across a number of investments, either directly or via special purpose investment vehicles.

Our Approach

Corvus aims to provide growth capital for proven assets and businesses, closing the gap between venture capital and PE houses specialised in buyout transactions. These include growth oriented opportunities, entrepreneurially driven companies, proven reserves and resources and established business models. Sector experience includes Energy, Commodities, Minerals, Specialist Financials, Insurance, Media, Technology & Health Care.

Our Approach


Our Strategy is to target assets or companies which we believe have significant inherent value which is not otherwise being achieved on behalf of shareholders. Working with partners with the appropriate skill sets and financial resources, we aim to invest in companies that can demonstrate the ability to produce strong income generation or have a proven or anticipated stable and cash-generating business. Typical deal situations include farm-in opportunities, expansion financing, management and shareholder buyouts and pre-IPO funding.


We love finding potential

Manoira Corporation

Manoira Corporationclick

Corvus is the founding and majority shareholder of Manoira Corporation, a specialty animal treatment company focused on developing proprietary intellectual property using solid form technology. Manoira specialise in the research and development of pharmaceutical and other health products for livestock and pets and intend to develop their portfolio of products to prevent and treat a variety of animal diseases and conditions.
Conduit Pharmaceuticals

Conduit Pharmaceuticalsclick

Corvus is the founding and majority shareholder of Conduit Pharmaceuticals, a disease agnostic life science company providing an efficient model for compound development. Conduit successfully completed a business combination with Murphy Canyon Acquisition Corp. in September 2023 for a proforma enterprise value of approximately $720 MM. (Nasdaq: CDT)
East Imperial Plc

East Imperial Plcclick

Corvus Capital is pleased to have advised Taylor Partners, the activist shareholder of East Imperial plc (LON: EISB), alongside Strand Hanson, on Taylor Partner's successful proposition to make a number of Board changes at EISB.
Ebers Tech Inc.

Ebers Tech

Corvus is the founding shareholder of Ebers Tech Inc., a private Canadian pharmaceutical company that utilises Co-crystallization and other technology to generate and monetize unique patented compounds and Intellectual Property around cannabinoids and psychedelics.


Corvus originated and negotiated Nuformix’s successful listing on the London Stock Exchange, by way of a Reverse Takeover by Levrett Plc, delivering 120x return for original investors.

ASOS Plcclick

Corvus Capital was one of the founding shareholders in ASOS Plc. now the UK’s largest independent online fashion and beauty retailer.


Corvus was the founding shareholder & principal provider of capital to AIM listed CloudTag.
Lodore Resources

Lodore Resourcesclick

Corvus was a founding shareholder and structured the initial finance for the flotation of Lodore Resources plc.